Adma Biologics (ADMA) Change in Cash (2011 - 2025)

Adma Biologics' Change in Cash history runs 13 years deep, the most recent figure standing at $26.2 million for Q4 2025.

• Quarterly Change in Cash rose 59.64% year-over-year to $26.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$15.5 million (down 129.96% YoY) and the FY2025 annual result came in at -$15.5 million, down 129.96% from the prior year.
• Change in Cash was $26.2 million for Q4 2025 at Adma Biologics, up from -$28.9 million in the prior quarter.
• Across five years, Change in Cash topped out at $51.6 million in Q4 2022 and bottomed at -$31.5 million in Q1 2025.
• A 5-year average of $1.6 million and a median of -$3.8 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2024 — Change in Cash jumped 741.44% — and 2025, when it plunged 1780.29%.
• Adma Biologics' Change in Cash stood at $16.7 million in 2021, then soared by 209.48% to $51.6 million in 2022, then sank by 144.18% to -$22.8 million in 2023, then surged by 172.09% to $16.4 million in 2024, then surged by 59.64% to $26.2 million in 2025.
• Business Quant data shows ADMA's Change in Cash at $26.2 million in Q4 2025, -$28.9 million in Q3 2025, and $18.7 million in Q2 2025.